As part of HEAP’s “Symposium Highlights” series, Kurt Zatloukal, Head of the Diagnostic and Research Center for Molecular BioMedicine, Medical University Graz, and Director of, Austria, discusses how biobanks could add value to exposome research in a 15-minute presentation.

Biobanks have expertise in collecting, preserving and providing access to biosamples, as well as processing health data in an ethically and legally compliant, and quality controlled manner. 

By combining exposome data with biosamples that are linked with health data, the individual genome can be sequenced and by using multi –omics approaches insight into molecular diseases mechanisms and disease outcomes can be obtained. 

Scroll to Top